George Dangas, MD, PhD, Named President of Society for Cardiovascular Angiography & Interventions
First Mount Sinai cardiologist to hold this prestigious position
The Society for Cardiovascular Angiography & Interventions (SCAI) has named George Dangas, MD, PhD, Professor of Medicine (Cardiology), and Surgery, at the Icahn School of Medicine at Mount Sinai as its new President. He was appointed on Saturday, May 20, during the closing ceremonies at the SCAI 2023 Scientific Sessions in Phoenix. He is the first Mount Sinai cardiologist to hold this position and will serve as the 46th President of SCAI.
Dr. Dangas, also the Director of Cardiovascular Innovation at the Zena and Michael A. Wiener Cardiovascular Institute at Icahn Mount Sinai and Chief of Cardiology at Mount Sinai Queens, is an authoritative voice on the performance of nonsurgical cardiovascular and valve interventions using both established and novel techniques, and on preventing and dissolving endovascular thrombosis. In his work with SCAI, he has served as a key faculty and program committee member for various meetings and events and is a former SCAI Trustee.
“I am deeply honored to serve as SCAI president this year,” said Dr. Dangas. “Our society is moving the interventional cardiology specialty forward in such impactful ways that are reflective of our current times and speak to the innovation required to advance patient care. I am excited to collaborate with our physician and associate members to address the needs of our profession and make an imprint on global health.”
In this new role, Dr. Dangas will fulfill a number of important responsibilities including acting as the spokesperson for SCAI, supporting its development efforts, and helping manage its operations.
Dr. Dangas completed medical and postgraduate studies at the National and Capodistrian University of Athens, Greece, followed by his internship and residency in internal medicine at The Miriam Hospital and Brown University in Providence, Rhode Island. He completed his cardiovascular disease and interventional cardiology fellowships at The Mount Sinai Hospital in New York City and has been certified by the American Board of Internal Medicine in Cardiovascular Disease and Interventional Cardiology, and also elected Master of the American College of Cardiology.
Dr. Dangas will begin his one-year term starting May 20, 2023.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
